New Safety Data and Ongoing Cardiovascular Trials

Program: CMES Ancillary Events
Session: CMES2-Applying the Evidence for GLP-1 Receptor Agonists in Type 2 Diabetes: Practice Perspectives
Clinical
Supported by an educational grant from AstraZeneca
Friday, March 6, 2015: 5:45 AM-8:00 AM
Presentation Start Time: 6:35 AM
Sapphire B (Hilton San Diego Bayfront)
Anne L Peters, MD
Keck School of Medicine of the University of Southern California, Los Angeles, CA

Disclosure Not Provided: ALP